Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014:2014:807196.
doi: 10.1155/2014/807196. Epub 2014 Mar 30.

First trimester biomarkers in the prediction of later pregnancy complications

Stefan C Kane  1 , Fabricio da Silva Costa  2 , Shaun Brennecke  3
Affiliations
Review

First trimester biomarkers in the prediction of later pregnancy complications

Stefan C Kane et al. Biomed Res Int. 2014.

Abstract

Adverse obstetric outcomes, such as preeclampsia, preterm birth, gestational diabetes, and fetal growth restriction, are poorly predicted by maternal history and risk factors alone, especially in nulliparae. The ability to predict these outcomes from the first trimester would allow for the early initiation of prophylactic therapies, institution of an appropriate model and location of care, and recruitment of a truly "high risk" population to clinical trials of interventions to prevent or ameliorate these conditions. To this end, development of adequately sensitive and specific predictive tests for these outcomes has become a significant focus of perinatal research. This paper reviews the biomarkers involved in these multiparametric tests and also outlines the performance of these tests and issues regarding their introduction into clinical practice.

PubMed Disclaimer

References

    1. NHS National Institute for Health and Clinical Excellence. Antenatal care. NICE Clinical Guideline 62, London, UK, 2010.
    1. Cuckle HS. Screening for pre-eclampsia—lessons from aneuploidy screening. Placenta. 2011;32:S42–S48. - PubMed
    1. Atkinson A.J. J, Colburn WA, DeGruttola VG, et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics. 2001;69(3):89–95. - PubMed
    1. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. British Medical Journal. 2005;330(7491):565–567. - PMC - PubMed
    1. Esplin MS, O’Brien E, Fraser A, et al. Estimating recurrence of spontaneous preterm delivery. Obstetrics and Gynecology. 2008;112(3):516–523. - PubMed